Research article
Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study
Michael D. Hill, Alastair M. Buchan and ; for The Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators
CMAJ May 10, 2005 172 (10) 1307-1312; DOI: https://doi.org/10.1503/cmaj.1041561
Article Information
vol. 172 no. 10 1307-1312
PubMed
History
- Published online May 9, 2005.
Copyright & Usage
© 2005 CMA Media Inc. or its licensors
Author Information
- Michael D. Hill,
- Alastair M. Buchan,
- for The Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators
- Michael Hill and Alastair Buchan are with the Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Calgary, Alta. A list of CASES Investigators and representatives of organizations involved with CASES appears in an online appendix (www.cmaj.ca/cgi/content/full/172/10/1307/DC1).
- Correspondence to:
Dr. Alastair M. Buchan, Professor of Clinical Geratology, University of Oxford, Acute Stroke Programme, Nuffield Department of Clinical Medicine, Level 7, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK; fax +44 (0) 1865 222 901; alastair.buchan{at}ndm.ox.ac.uk
Statistics from Altmetric.com
In this issue
Article tools
Respond to this article
Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study
Michael D. Hill, Alastair M. Buchan
CMAJ May 2005, 172 (10) 1307-1312; DOI: 10.1503/cmaj.1041561
Jump to section
Related Articles
Cited By...
- Tenecteplase 0.4 mg/kg in moderate and severe acute ischemic stroke: A pooled analysis of NOR-TEST & NOR-TEST 2A
- Differential Contribution of ASPECTS Regions to Clinical Outcome after Thrombectomy for Acute Ischemic Stroke
- Correlation between ASPECTS and Core Volume on CT Perfusion: Impact of Time since Stroke Onset and Presence of Large-Vessel Occlusion
- Region-specific agreement in ASPECTS estimation between neuroradiologists and e-ASPECTS software
- Use of MRI to predict symptomatic haemorrhagic transformation after thrombolysis for cerebral ischaemia
- Pediatric ASPECTS predicts outcomes following acute symptomatic neonatal arterial stroke
- Clinical Utility of Electronic Alberta Stroke Program Early Computed Tomography Score Software in the ENCHANTED Trial Database
- Long-term stroke prevention: We can do better
- Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke
- Good Intracranial Collaterals Trump Poor ASPECTS (Alberta Stroke Program Early CT Score) for Intravenous Thrombolysis in Anterior Circulation Acute Ischemic Stroke
- Orolingual Angioedema During or After Thrombolysis for Cerebral Ischemia
- Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
- Is more really better?: The effect of enrollment volume on outcomes for medical therapies
- Incidence, predictors and clinical characteristics of orolingual angio-oedema complicating thrombolysis with tissue plasminogen activator for ischaemic stroke
- Elevated pretreatment blood pressure and IV thrombolysis in stroke
- Endovascular treatment of tandem vascular occlusions in acute ischemic stroke
- The quality of treatment of hyperacute ischemic stroke in Canada: a retrospective chart audit
- Alberta Stroke Program Early Computed Tomography Score to Select Patients for Endovascular Treatment: Interventional Management of Stroke (IMS)-III Trial
- Stroke thrombolysis: where are we and where are we going?
- Do risks outweigh benefits in thrombolysis for stroke?
- A Case-Controlled Comparison of Thrombolysis Outcomes Between Wake-Up and Known Time of Onset Ischemic Stroke Patients
- Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
- Reperfusion Therapy in Unclear-Onset Stroke Based on MRI Evaluation (RESTORE): A Prospective Multicenter Study
- Airway management in a patient with severe angioedema after thrombolysis for ischemic stroke
- Does the Application of X-Ray Contrast Agents Impair the Clinical Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients?
- Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated With Intravenous Alteplase: Safe Implementation of Treatments in Stroke (SITS) Symptomatic Intracerebral Hemorrhage Risk Score
- Impact of Thrombolysis on Stroke Outcome at 12 Months in a Population: The Bern Stroke Project
- Stroke Epidemiology, Patterns of Management, and Outcomes in Fortaleza, Brazil: A Hospital-Based Multicenter Prospective Study
- Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis
- Attitudes and Beliefs of Michigan Emergency Physicians Toward Tissue Plasminogen Activator Use in Stroke: Baseline Survey Results From the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) Trial Hospitals
- Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical Practice: The Japan post-Marketing Alteplase Registration Study (J-MARS)
- Outcomes of Thrombolysis for Acute Ischemic Stroke in Octogenarians Versus Nonagenarians
- The "Golden Hour" and Acute Brain Ischemia: Presenting Features and Lytic Therapy in >30 000 Patients Arriving Within 60 Minutes of Stroke Onset
- Set up and run a thrombolysis service for acute stroke
- Outcomes of Thrombolytic Therapy for Acute Ischemic Stroke in Chinese Patients: The Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study
- Medication Errors in Acute Cardiovascular and Stroke Patients: A Scientific Statement From the American Heart Association
- A Citywide Prehospital Protocol Increases Access to Stroke Thrombolysis in Toronto
- Routine Use of Intravenous Low-Dose Recombinant Tissue Plasminogen Activator in Japanese Patients: General Outcomes and Prognostic Factors From the SAMURAI Register
- Pre-Tissue Plasminogen Activator Blood Pressure Levels and Risk of Symptomatic Intracerebral Hemorrhage
- Factors Associated With Intracerebral Hemorrhage After Thrombolytic Therapy for Ischemic Stroke: Pooled Analysis of Placebo Data From the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials
- Review of current and emerging therapies in acute ischemic stroke
- Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous Thrombolysis
- Thrombolysis for ischaemic stroke and glioblastoma multiforme: a case report
- Thrombolytic therapy with alteplase for ischaemic stroke
- Impact of the Approval of Intravenous Recombinant Tissue Plasminogen Activator Therapy on the Processes of Acute Stroke Management in Japan: The Stroke Unit Multicenter Observational (SUMO) Study
- The gender effect in stroke thrombolysis: Of CASES, controls, and treatment-effect modification
- Haemorrhagic transformation in acute ischaemic stroke following thrombolysis therapy: classification, pathogenesis and risk factors
- Is It Time to Definitely Abandon Neuroprotection in Acute Ischemic Stroke?
- MRI-Based and CT-Based Thrombolytic Therapy in Acute Stroke Within and Beyond Established Time Windows: An Analysis of 1210 Patients
- Risk Factors of Symptomatic Intracerebral Hemorrhage After tPA Therapy for Acute Stroke
- Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome
- Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada
- Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke
- Differential Prognosis of Isolated Cortical Swelling and Hypoattenuation on CT in Acute Stroke
- Site of Arterial Occlusion Identified by Transcranial Doppler Predicts the Response to Intravenous Thrombolysis for Stroke
- Asymptomatic Hemorrhage After Thrombolysis May Not Be Benign: Prognosis by Hemorrhage Type in the Canadian Alteplase for Stroke Effectiveness Study Registry
- Acute stroke treatment: the end of the first decade
- Translational vehicles for neuroprotection
- An Expedited Code Stroke Protocol Is Feasible and Safe
- How well does ASPECTS predict the outcome of acute stroke treated with IV tPA?
- Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study
- Comparison of Tissue Plasminogen Activator Administration Management Between Telestroke Network Hospitals and Academic Stroke Centers: The Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany
- Insular cortical ischaemia does not independently predict acute hypertension or hyperglycaemia within 3 h of onset
- Referral Bias May Underestimate Number of Very Elderly Patients Eligible for rtPA
- Is old age really a reason to withhold thrombolytic therapy?
- Factors Associated With In-Hospital Mortality After Administration of Thrombolysis in Acute Ischemic Stroke Patients: An Analysis of the Nationwide Inpatient Sample 1999 to 2002
- Part 9: Adult Stroke
- Gender Differences in tPA-Related Arterial Recanalization * Response:
- Diagnostic Biomarkers for Stroke: A Stroke Neurologist's Perspective
- MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
- More Evidence in Support of Thrombolysis for Acute Stroke
- Minerva
- Research suggests thrombolysis is effective for acute ischaemic stroke